Blood-testing firm aims to turn over assets, cash within a year
(Newser) -
Last one out, shut off the lights: A Silicon Valley darling before investors lost $1 billion , blood-testing firm Theranos will soon be no more. After years of scandal and failed attempts to sell the company, its cash dipped too low, according to a $65 million loan agreement with Fortress Investment...